“…1,2,3‐triazole is ubiquitous in numerous biologically active molecules and pharmaceuticals as triazoles are believed to be stable against metabolic degradation because of its structural and electronic similarity. On the other hand, 1,3,4‐oxadiazole ring is reported to improve ligand binding, flexibility, polarity, pharmacokinetics, in vivo metabolic profile, and aids in the design of molecules for the generation of newer derivatives that makes better interaction with receptors . Worthy to mention here that 1,3,4‐oxadiazole based anticancer drug, Zibotentan, is in late clinical trials, whereas, letrozole and anastrozole are triazole based drugs targeting aromatase that are used to treat breast cancer .…”